Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | PO / MO |
The patient took third dose of Vivotif on time, but about 10 minutes later, had a couple of grapes; The patient took third dose of Vivotif on time, but about 10 minutes later, had a couple of grapes; Case reference number US-BN-2025-002024 is a spontaneous case initially received from nurse via Bavarian Nordic (reference number: CASE-001394) on 30-Dec-2025 and concerns an 18-years-old male patient. The patient's medical history and concomitant medications details were provided. On 24-Dec-2025, the patient took first dose of Vivotif vaccine (batch number: unknown), at unknown dose, orally, for unknown indication. On an unspecified date, unknown time after first dose, the patient took second dose of Vivotif vaccine (batch number: unknown), at unknown dose, orally. On an unspecified date, unknown time after first dose, the patient took third dose of Vivotif vaccine (batch number: unknown), at unknown dose, orally. As reported, the patient took his third dose on time, but about 10 minutes later, he had a couple of grapes (explicitly coded as "product administration error'). On 30-Dec-2025, reported as today, the patient was supposed to take his final dose of Vivotif at about 08:15 or 08:30, and forgot to take it, and will not be able to take it until almost 10:00 at the time of this report (explicitly coded as 'missed dose'). At the time of initial report, it was unknown if the patient experienced any adverse event due to the Vivotif. No further information was provided.; Reporter's Comments: An 18-year-old male patient took the third dose of Vivotif vaccine, but about 10 minutes later, he had a couple of grapes, which is considered as product administration error. The patient was supposed to take his final dose of Vivotif and forgot to take it, which is considered as missed dose. It was unknown if the patient experienced any adverse event due to the Vivotif. Product administration error and product dose omission issue are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error and product dose omission issue are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: An 18-year-old male patient took the third dose of Vivotif vaccine, but about 10 minutes later, he had a couple of grapes, which is considered as product administration error. The patient was supposed to take his final dose of Vivotif and forgot to take it, which is considered as missed dose. It was unknown if the patient experienced any adverse event due to the Vivotif. Product administration error and product dose omission issue are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error and product dose omission issue are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.